Top 10 Companies in the (S)-1-(2-Fluorophenyl)-1-Propanol Market (2026): Market Leaders Driving Global Pharmaceutical Innovation

MARKET INSIGHTS

The global (S)-1-(2-Fluorophenyl)-1-propanol market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.7 million by 2034, exhibiting a CAGR of 6.4% during the forecast period.

(S)-1-(2-Fluorophenyl)-1-propanol is a chiral secondary alcohol bearing a fluorine substituent at the ortho position of the phenyl ring. With the molecular formula C₉H₁₁FO, this enantiomerically pure compound serves as a valuable chiral building block and intermediate in the synthesis of active pharmaceutical ingredients (APIs), agrochemicals, and specialty fine chemicals. Its well-defined stereochemistry makes it particularly important in asymmetric synthesis, where precise molecular configuration directly influences biological activity and therapeutic efficacy.

The market is witnessing steady growth driven by rising demand for enantioselective synthesis across the pharmaceutical industry, where regulatory agencies increasingly require single-enantiomer drug formulations. Furthermore, advancements in asymmetric catalysis and biocatalytic reduction technologies have enhanced the cost‑effective production of this compound at commercial scale. Key manufacturers and fine chemical suppliers operating in this space include BASF SE, Thermo Fisher Scientific, TCI Chemicals, and Sigma‑Aldrich (Merck KGaA), among others contributing to expanding global supply capabilities.

(S)-1-(2-Fluorophenyl)-1-Propanol Market – View in Detailed Research Report

🔟 1. BASF SE

Headquarters: Ludwigshafen, Germany
Key Offering: Comprehensive range of fine chemicals and chiral intermediates for pharmaceutical development.

BASF SE is a global leader in chemical manufacturing, providing high‑purity (S)-1-(2‑Fluorophenyl)-1‑propanol for API synthesis. Their advanced asymmetric reduction processes ensure consistent enantiomeric excess above 99%, meeting stringent regulatory standards.

Sustainability Initiatives:

• Investment in green chemistry and biocatalytic routes.
• Reduction of process mass intensity (PMI) by 20% over five years.
• Commitment to achieving net‑zero emissions by 2050.

9️⃣ 2. Thermo Fisher Scientific

Headquarters: Waltham, Massachusetts, USA
Key Offering: Specialty chemicals and analytical services for pharmaceutical R&D.

Thermo Fisher provides high‑purity (S)-1‑(2‑Fluorophenyl)-1‑propanol with rigorous chiral purity verification, supporting contract research organizations worldwide.

Sustainability Initiatives:

• Adoption of renewable energy across manufacturing sites.
• Development of enzymatic resolution processes to replace hazardous solvents.
• Transparent reporting of carbon footprint and waste metrics.

8️⃣ 3. TCI Chemicals

Headquarters: Tokyo, Japan
Key Offering: High‑quality chiral reagents and intermediates for API development.

TCI delivers (S)-1‑(2‑Fluorophenyl)-1‑propanol with customizable grades, catering to both research and commercial production needs.

Sustainability Initiatives:

• Implementation of water‑recycling systems in synthesis plants.
• Partnerships with academic institutions for biocatalysis research.
• ISO 14001 certification for environmental management.

7️⃣ 4. Sigma‑Aldrich (Merck KGaA)

Headquarters: Darmstadt, Germany
Key Offering: Premium chiral reagents and catalysts for pharmaceutical synthesis.

Sigma‑Aldrich offers (S)-1‑(2‑Fluorophenyl)-1‑propanol in GMP‑grade formulations, supporting large‑scale API manufacturing.

Sustainability Initiatives:

• Reduction of hazardous waste by 30% through process optimization.
• Use of biodegradable packaging materials.
• Commitment to the Circular Economy in chemical production.

6️⃣ 5. Capot Chemical Co., Ltd.

Headquarters: Guangzhou, China
Key Offering: Scalable production of chiral intermediates for pharmaceutical companies.

Capot Chemical specializes in asymmetric synthesis of (S)-1‑(2‑Fluorophenyl)-1‑propanol, providing high‑purity grades at commercial scale.

Sustainability Initiatives:

• Adoption of renewable energy sources in production facilities.
• Investment in biocatalytic processes to reduce solvent usage.
• Compliance with ISO 9001 and ISO 14001 standards.

5️⃣ 6. Hairui Chemical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Custom synthesis services for chiral alcohols and derivatives.

Hairui Chemical provides (S)-1‑(2‑Fluorophenyl)-1‑propanol in both technical and pharmaceutical grades, with rapid turnaround times.

Sustainability Initiatives:

• Implementation of green chemistry protocols across all synthesis lines.
• Partnerships with universities for catalyst development.
• Zero‑waste production targets by 2030.

4️⃣ 7. Finetech Industry Limited

Headquarters: Shenzhen, China
Key Offering: High‑purity chiral intermediates and custom synthesis solutions.

Finetech delivers (S)-1‑(2‑Fluorophenyl)-1‑propanol with stringent quality control, supporting both R&D and commercial production.

Sustainability Initiatives:

• Use of enzyme‑based reduction methods to minimize toxic reagents.
• Energy‑efficient manufacturing processes.
• Corporate social responsibility programs focused on community development.

3️⃣ 8. Chemenu Inc.

Headquarters: Shanghai, China
Key Offering: Custom synthesis of chiral alcohols and fine chemicals.

Chemenu provides (S)-1‑(2‑Fluorophenyl)-1‑propanol with high enantiomeric excess, catering to both academic and industrial clients.

Sustainability Initiatives:

• Adoption of renewable energy in production sites.
• Continuous improvement of process efficiency to lower PMI.
• Transparent environmental reporting.

2️⃣ 9. PharmaBlock Sciences (Nanjing) Inc.

Headquarters: Nanjing, China
Key Offering: High‑purity chiral intermediates for API development.

PharmaBlock Sciences supplies (S)-1‑(2‑Fluorophenyl)-1‑propanol in GMP‑grade format, supporting large‑scale pharmaceutical production.

Sustainability Initiatives:

• Implementation of green chemistry principles across synthesis routes.
• Investment in biocatalytic reduction technologies.
• Commitment to reduce CO₂ emissions by 25% by 2028.

1️⃣ 10. Enamine Ltd.

Headquarters: Kyiv, Ukraine
Key Offering: Comprehensive library of chiral building blocks for medicinal chemistry.

Enamine offers (S)-1‑(2‑Fluorophenyl)-1‑propanol in various grades, supporting academic research and early‑stage drug discovery.

Sustainability Initiatives:

• Use of renewable energy sources in laboratories.
• Development of environmentally friendly synthetic routes.
• Support for open‑access research and data sharing.

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/307720/propanol-market

Get Full Report Here: https://www.24chemicalresearch.com/reports/307720/propanol-market

Market Outlook

The (S)-1‑(2‑Fluorophenyl)-1‑propanol market is projected to expand steadily, driven by the increasing demand for chiral intermediates in API synthesis, particularly within CNS and cardiovascular therapeutic areas. The shift towards green chemistry and biocatalytic production methods is expected to lower production costs and improve scalability, fostering broader adoption across the pharmaceutical and fine‑chemical sectors.

Future Trends

• Growth of biocatalytic asymmetric reduction technologies, enabling higher enantiomeric excess with lower environmental impact.
• Expansion of contract development and manufacturing organizations (CDMOs) seeking high‑purity chiral building blocks for early‑stage drug discovery.
• Increased regulatory emphasis on single‑enantiomer drugs, driving demand for GMP‑grade (S)-1‑(2‑Fluorophenyl)-1‑propanol.
• Emerging applications in agrochemicals and specialty fine chemicals, leveraging fluorination for improved performance.
• Continued investment in Asia‑Pacific manufacturing hubs, enhancing supply chain resilience and reducing lead times.